Evidence map›Paper›PMID 24931007›Full record

ArticleAlcoholism, clinical and experimental research2014

Dysmorphogenic effects of first trimester-equivalent ethanol exposure in mice: a magnetic resonance microscopy-based study.

Scott E Parnell, Hunter E Holloway, Lorinda K Baker, Martin A Styner, Kathleen K Sulik

Open access · greenAbstract read
In one paragraph

Article in Alcoholism, clinical and experimental research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
6.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Scott E ParnellBowles Center for Alcohol Studies, University of North Carolina, Chapel Hill, North Carolina; Carolina Institute for Developmental Disabilities, University of North Carolina, Chapel Hill, North Carolina; Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, North Carolina.
Hunter E Holloway
Lorinda K Baker
Martin A Styner
Kathleen K Sulik
University of North Carolina at Chapel Hill · US

Funding

UNC ARC Information/Dissemination CoreP60AA011605 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A Herman · 2003 to 2026
$46.3M
Washington University ConsoritumU54EB005149 · NIBIB · BRIGHAM AND WOMEN'S HOSPITAL · PI KIKINIS, RON · 2004 to 2013
$39.3M
UNC MRDD Research CenterP30HD003110 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI REZNICK, JAMES · 1985 to 2012
$28.7M
Preclinical CoreU54HD079124 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BELGER, AYSENIL · 2013 to 2019
$8.0M
INTEGRATED CENTER FOR IN VIVO MICROSCOPYP41EB015897 · NIBIB · DUKE UNIVERSITY · PI JOHNSON, GEORGE ALLAN · 2012 to 2017
$7.4M
Exploring the Genetics of FASD in Complementary Mouse and Fish ModelsU01AA021651 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI EBERHART, JOHANN K, PARNELL, SCOTT · 2012 to 2021
$3.2M
MAGNETIC RESONANCE AND DIFFUSION TENSOR IMAGING OF A MOUSE FASD MODEL U01U01AA017124 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SULIK, KATHLEEN K · 2007 to 2011
$1.2M
Neuroanatomical/Functional Correlates in an FASD ModelR00AA018697 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PARNELL, SCOTT · 2012 to 2014
$710k
Neuroanatomical/Functional Correlates in an FASD ModelK99AA018697 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PARNELL, SCOTT · 2010 to 2011
$180k
NIAAA NIH HHS K99 AA018697NIAAA NIH HHS K99/R00-AA018697NIAAA NIH HHS P60 AA011605NIAAA NIH HHS P60-AA011605NIAAA NIH HHS R00 AA018697NIAAA NIH HHS U01 AA017124NIAAA NIH HHS U01-AA017124NIAAA NIH HHS U01 AA021651NIAAA NIH HHS U01-AA021651NIBIB NIH HHS P41 EB015897NIBIB NIH HHS P41-EB015897NIBIB NIH HHS U54 EB005149NIBIB NIH HHS U54-EB005149-01NICHD NIH HHS P30 HD003110NICHD NIH HHS P30-HD03110NICHD NIH HHS U54 HD079124
6 · The paper itself

Abstract

backgroundThe first trimester of human development and the equivalent developmental period in animal models is a time when teratogenic ethanol (EtOH) exposure induces the major structural birth defects that fall within fetal alcohol spectrum disorder (FASD). Previous FASD research employing an acute high dose maternal intraperitoneal EtOH treatment paradigm has identified sensitive periods for a number of these defects. Extending this work, this investigation utilized high resolution magnetic resonance microscopy (MRM)-based analyses to examine the dysmorphology resulting from maternal dietary EtOH intake occurring during selected first trimester-equivalent time periods.

methodsFemale C57Bl/6J mice were acclimated to a liquid 4.8% EtOH (v/v)-containing diet, then bred while on standard chow. Dams were again provided the EtOH-containing liquid diet for a period that extended either from the beginning of gestational day (GD) 7 to the end of GD 11 or from the beginning of GD 12 to the end of GD 16. On GD 17, a subset of fetuses was selected for MRM-based analyses. Group comparisons were made for litter characteristics and gross dysmorphology, as well as whole and regional brain volumes.

resultsEtOH-induced stage of exposure-dependent structural brain abnormalities were observed. The GD 7 to 11 EtOH-exposed group presented with a significant decrease in cerebellar volume and an increase in septal volume, while GD 12 to 16 EtOH treatment resulted in a reduction in right hippocampal volume accompanied by enlarged pituitaries. Additionally, the GD 12 to 16 EtOH exposure caused a high incidence of edema/fetal hydrops.

conclusionsThese results illustrate the teratogenic impact of maternal dietary EtOH intake occurring at time periods approximately equivalent to weeks 3 through 6 (GD 7 to 11 in mice) and weeks 7 through 12 (GD 12 to 16 in mice) of human gestation, further documenting EtOH's stage of exposure-dependent neuroteratogenic end points and highlighting the vulnerability of selected brain regions during the first trimester. Additionally they suggest that clinical attention should be paid to fetal hydrops as a likely component of FASD.

Indexed as

Pregnancy Trimester, FirstAbnormalities, Drug-InducedAnimalsBrainEthanolFemaleHydrops FetalisMagnetic Resonance ImagingMaleMiceNeuroimagingPituitary GlandPregnancyEthanolBrainEthanolFetal Alcohol Spectrum DisorderMagnetic Resonance MicroscopyMouse

Identifiers

PMID24931007
PMCPMC4107075
OpenAlexW2105069674

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.